Stryker to Acquire ZuriMED, Expanding Rotator Cuff Augmentation Portfolio

Stryker, a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and develop...

September 02, 2026 | Wednesday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
Eisai and Biogen’s LEQEMBI Gains Canada Recommendation for Public Reimbursement in Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc., announced that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of...

September 02, 2026 | Wednesday | News
10x Genomics Wins $4.8 Million Patent Infringement Verdict Against Parse Biosciences

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health, announced that a jury in the U.S. Dist...

August 31, 2026 | Monday | News
Quoin Reports Positive Interim Phase 2/3 Results for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and...

August 31, 2026 | Monday | News
Thermo Fisher Scientific Launches Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...

August 27, 2026 | Thursday | News
Caliway Advances CBL-514 With U.S. FDA Clearance and Phase 3 Trial Launch

Caliway Biopharmaceuticals, a clinical-stage biopharmaceutical company developing innovative small-molecule therapeutics, announced two major clinical mi...

August 27, 2026 | Thursday | News
Eisai and Biogen Launch Weekly Subcutaneous LEQEMBI IQLIK for Early Alzheimer’s in the U.S.

Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in th...

August 26, 2026 | Wednesday | News
Japan Grants Orphan Drug Designation to Alkeus’ Gildeuretinol for Stargardt Disease

Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that t...

August 26, 2026 | Wednesday | News
Leads Biolabs Advances Opamtistomig into Expansion Phase in First-Line Esophageal Cancer Trial

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,”  announced that Opamtistomig (LBL-024), the Company&rsquo...

August 26, 2026 | Wednesday | News
Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...

August 25, 2026 | Tuesday | Interaction
Ipsen Completes Acquisition of Kartos Therapeutics, Adding Phase III Myelofibrosis Drug Candidate

Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navt...

August 24, 2026 | Monday | News
Orum Therapeutics Wins FDA Clearance for ORM-1153 AML Degrader-Antibody Conjugate

Orum Therapeutics(“Orum” or the “Company”), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), ...

August 24, 2026 | Monday | News
ACTG Opens STAIR-HIV Trial to Evaluate Alendronate as an HIV Latency-Reversing Agent

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced the opening of STAIR-HIV (Small Trial of Alendronate Impac...

August 21, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close